OKYO Pharma Limited - Ordinary Shares - New
OKYO
Get informed when a big investor buys or sells
+ FollowMarket Cap$56.4M
Close$
$0.39
73.4% downside
Current Fair Value
73.4% downsideOvervalued by 73.4% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $56.40 Million |
|---|---|
| Enterprise Value | $41.81 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.24 |
| Beta | 0.05 |
| Outstanding Shares | 37,389,244 |
Return
| Return on Equity | -88.99% |
|---|---|
| Return on Assets | -52.33% |
| Return on Invested Capital | -102.67% |
Valuation & Multiples
| P/E Ratio | -6.15 |
|---|---|
| PEG | -2.87 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -3.3 |
| Enterprise Value to Net Income | -4 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 10, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationNext Earnings Call
Expected Date
December 2, 2026
EPS Estimate
$-0.06
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data